Evidence map›Paper›PMID 37345973›Full record

Observational studyActa dermato-venereologica2023

Perceived Stigmatization among Dermatological Outpatients Compared with Controls: An Observational Multicentre Study in 17 European Countries.

Sylvia Van Beugen, Christina Schut, Jörg Kupfer, Antony P Bewley, Andrew Y Finlay, Uwe Gieler, Andrew R Thompson, Tamara Gracia-Cazaña, Flora Balieva, Bárbara R Ferreira and 22 more

Open access · goldAbstract readObservational StudyMulticenter Study
In one paragraph

Observational study in Acta dermato-venereologica, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 1 pooled it
17.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 1 synthesis or guideline pooled it, 62 citations in OpenAlex.

  1. Pooled it
  2. Randomised, split-face study of a dermocosmetic cream containing Sphingobioma xenophaga extract and NeurosensineSkin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) · 2024
    Trial
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Suicidal ideation in patients with atopic dermatitis: A case-control study on 23,191 adults.Journal of the European Academy of Dermatology and Venereology : JEADV · 2026
    Article
  11. Article
  12. The exposomal imprint on rosacea: More than skin deep.Journal of the European Academy of Dermatology and Venereology : JEADV · 2026
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Evaluation of stigmatization in patients with hidradenitis suppurativa using the PUSH-D score.Journal of the European Academy of Dermatology and Venereology : JEADV · 2025
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors at 20 institutions in 17 countries.

Sylvia Van BeugenInstitute of Psychology, Health, Medical and Neuropsychology Unit, Leiden University, Leiden, the Netherlands. s.van.beugen@fsw.leidenuniv.nl.
Christina SchutInstitute of Medical Psychology, Justus-Liebig-University Gießen, Gießen, Germany.
Jörg KupferInstitute of Medical Psychology, Justus-Liebig-University Gießen, Gießen, Germany.
Antony P BewleyBarts Health NHS Trust & Queen Mary University, London, UK.
Andrew Y FinlayInstitute of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK.
Uwe GielerDepartment of Dermatology, Justus-Liebig- University Giessen and Vitos Klinik, Giessen, Germany.
Andrew R ThompsonSouth Wales Clinical Psychology Programme, Cardiff & Vale University Health Board, & School of Psychology, Cardiff University, UK.
Tamara Gracia-CazañaMiguel Servet University Hospital, IIS Aragón, Universidad de Zaragoza, Zaragoza, Spain.
Flora BalievaDepartment of Dermatology, Stavanger University Hospital, Stavanger, Norway.
Bárbara R FerreiraDepartment of Dermatology, Coimbra University Hospital, Coimbra, Portugal.
Gregor B JemecDepartment of Dermatology, Zealand University Hospital, Roskilde, Denmark.
Lars LienNorwegian National Advisory Unit on Concurrent Substance Abuse and Mental Health Disorders, Innlandet Hospital Trust, Brumunddal, Norway.
Laurent MiseryDepartment of Dermatology, University Hospital of Brest, Brest, France.
Servando E MarronDepartment of Dermatology, University Hospital Miguel Servet, Aragon Psychodermatology Research Group (GAI+PD), Zaragoza, Spain.
Sonja StänderDepartment of Dermatology, University Clinic Münster, Münster, Germany.
Claudia ZeidlerDepartment of Dermatology, University Clinic Münster, Münster, Germany.
Csanád SzabóInstitute of Psychology, University of Szeged, Szeged, Hungary.
Jacek C SzepietowskiDepartment of Dermatology, Venereology and Allergology, Wroclaw Medical University, Wroclaw, Poland.
Adam ReichDepartment of Dermatology, Institute of Medical Sciences, Medical College of Rzeszow University, Rzeszów, Poland.
Amna ElyasDepartment of Dermatology and Venereology, Skåne University Hospital, Malmo, Sweden.
Ilknur K AltunayUniversity of Health Sciences. Hamidiye Etfal Research and Training Hospital, Department of Dermatology and Venereology, Istanbul, Turkey.
Franz J LegatDepartment of Dermatology, Medical University of Graz, Graz, Austria.
Vesna Grivcheva-PanovskaUniversity St Cyril and Methodius, School of Medicine, PHI University Clinic of Dermatology Skopje, N. Macedonia.
Dmitry V RomanovDepartment of Psychiatry and Psychosomatics, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.
Andrey N LvovDepartment of Dermatovenereology and Cosmetology, Central State Medical Academy of department of presidential affairs, Moscow, Russia.
Géraldine TitecaDepartment of Dermatology/ Clinique Notre Dame de Grâce, Gosselies, Belgium.
Francesca SampognaClinical Epidemiology Unit, IDI-IRCCS, Rome, Italy.
Nienke C VulinkDepartment of Psychiatry, Amsterdam UMC, location AMC, Amsterdam, the Netherlands.
Lucia Tomás-AragonesDepartment of Psychology, University of Zaragoza, Zaragoza Spain.
Andrea W M EversInstitute of Psychology, Health, Medical and Neuropsychology Unit, Leiden University, Leiden, the Netherlands.
Florence J DalgardDepartment of Dermatology and Venereology, Skåne University Hospital, Malmo, Sweden.
European Society for Dermatology and Psychiatry (ESDaP) Study collaborators
Cardiff University · GBJustus-Liebig-Universität Gießen · DELeiden University · NLSkåne University Hospital · SEUniversidad de Zaragoza · ESUniversity Hospital Münster · DEAmsterdam University Medical Centers · NLBarts Health NHS Trust · GBCentral State Medical Academy · RUCentre Hospitalier Régional Universitaire de Brest · FRClinique Saint-Joseph · BEInnlandet Hospital Trust · NOIstituti di Ricovero e Cura a Carattere Scientifico · ITMedical University of Graz · ATRzeszów University · PLSağlık Bilimleri Üniversitesi · TRSechenov University · RUSs. Cyril and Methodius University in Skopje · MKStavanger University Hospital · NOUniversity of Coimbra · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Perceived stigmatization places a large psychosocial burden on patients with some skin conditions. Little is known about the experience of stigmatization across a wide range of skin diseases. This observational cross-sectional study aimed to quantify perceived stigmatization and identify its predictors among patients with a broad spectrum of skin diseases across 17 European countries. Self-report questionnaires assessing perceived stigmatization and its potential predictors were completed by 5,487 dermatology outpatients and 2,808 skin-healthy controls. Dermatological diagnosis, severity, and comorbidity were clinician-assessed. Patients experienced higher levels of perceived stigmatization than controls (p < 0.001, d   = 0.26); patients with psoriasis, atopic dermatitis, alopecia, and bullous disorders were particularly affected. Multivariate regression analyses showed that perceived stigmatization was related to sociodemographic (lower age, male sex, being single), general health-related (higher body mass index, lower overall health), disease-related (higher clinician-assessed disease severity, presence of itch, longer disease duration), and psychological (greater distress, presence of suicidal ideation, greater body dysmorphic concerns, lower appearance satisfaction) variables. To conclude, perceived stigmatization is common in patients with skin diseases. Factors have been identified that will help clinicians and policymakers to target vulnerable patient groups, offer adequate patient management, and to ultimately develop evidence-based interventions.

Indexed as

PsoriasisSkin DiseasesHumansMaleOutpatientsQuality of LifeStereotypingSurveys and Questionnaires

Identifiers

PMID37345973
PMCPMC10296546
OpenAlexW4381597502

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.